Clinical Trial

Sebum Metabolomics and Lipidomics for Clinical Applications

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to develop a standardized workflow for sebum sampling and metabolomics/lipidomics analysis using Sebutape. A total of 200 participants will be recruited, including healthy individuals, patients with skin diseases, individuals undergoing dermatological treatments or using skincare products, and a subset of healthy participants receiving short-term topical antibiotic intervention. The study will investigate sebum composition, skin microbiome profiles, and their interactions under different conditions to explore potential biomarkers and clinical applications.
Trial Details
NCT Number NCT07549828
Lead Sponsor National Taiwan University Hospital
Conditions Acne, Atopic Dermatitis, Seborrheic Dermatitis, Psoriasis, Healthy Subjects (HS)
Enrollment 200 participants
Start Date 2026-04-01
Primary Completion 2029-03-31 (estimated)
Study Completion 2029-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-24